Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Short-term Investments: 2010-2025

Historic Short-term Investments for Rockwell Medical (RMTI) over the last 16 years, with Sep 2025 value amounting to $10.1 million.

  • Rockwell Medical's Short-term Investments rose 70.16% to $10.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.1 million, marking a year-over-year increase of 70.16%. This contributed to the annual value of $5.9 million for FY2024, which is 204.30% up from last year.
  • As of Q3 2025, Rockwell Medical's Short-term Investments stood at $10.1 million, which was up 69.98% from $5.9 million recorded in Q2 2025.
  • Over the past 5 years, Rockwell Medical's Short-term Investments peaked at $14.6 million during Q3 2022, and registered a low of $2.0 million during Q4 2023.
  • Its 3-year average for Short-term Investments is $5.4 million, with a median of $5.9 million in 2023.
  • In the last 5 years, Rockwell Medical's Short-term Investments tumbled by 82.86% in 2023 and then skyrocketed by 204.30% in 2024.
  • MRQ analysis of 5 years shows Rockwell Medical's Short-term Investments stood at $9.2 million in 2021, then rose by 24.37% to $11.4 million in 2022, then plummeted by 82.86% to $2.0 million in 2023, then surged by 204.30% to $5.9 million in 2024, then surged by 69.98% to $10.1 million in 2025.
  • Its Short-term Investments stands at $10.1 million for Q3 2025, versus $5.9 million for Q2 2025 and $5.9 million for Q1 2025.